Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
112.90
+1.44 (1.29%)
May 12, 2026, 4:00 PM EDT - Market closed
Agilent Technologies Revenue
Agilent Technologies had revenue of $1.80B in the quarter ending January 31, 2026, with 6.96% growth. This brings the company's revenue in the last twelve months to $7.07B, up 8.14% year-over-year. In the fiscal year ending October 31, 2025, Agilent Technologies had annual revenue of $6.95B with 6.73% growth.
Revenue (ttm)
$7.07B
Revenue Growth
+8.14%
P/S Ratio
4.52
Revenue / Employee
$390,331
Employees
18,100
Market Cap
31.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 6.95B | 438.00M | 6.73% |
| Oct 31, 2024 | 6.51B | -323.00M | -4.73% |
| Oct 31, 2023 | 6.83B | -15.00M | -0.22% |
| Oct 31, 2022 | 6.85B | 529.00M | 8.37% |
| Oct 31, 2021 | 6.32B | 980.00M | 18.36% |
| Oct 31, 2020 | 5.34B | 176.00M | 3.41% |
| Oct 31, 2019 | 5.16B | 249.00M | 5.07% |
| Oct 31, 2018 | 4.91B | 442.00M | 9.88% |
| Oct 31, 2017 | 4.47B | 270.00M | 6.43% |
| Oct 31, 2016 | 4.20B | 164.00M | 4.06% |
| Oct 31, 2015 | 4.04B | -10.00M | -0.25% |
| Oct 31, 2014 | 4.05B | 154.00M | 3.95% |
| Oct 31, 2013 | 3.89B | -2.96B | -43.22% |
| Oct 31, 2012 | 6.86B | 243.00M | 3.67% |
| Oct 31, 2011 | 6.62B | 1.17B | 21.51% |
| Oct 31, 2010 | 5.44B | 963.00M | 21.49% |
| Oct 31, 2009 | 4.48B | -1.29B | -22.39% |
| Oct 31, 2008 | 5.77B | 354.00M | 6.53% |
| Oct 31, 2007 | 5.42B | 447.00M | 8.99% |
| Oct 31, 2006 | 4.97B | 288.00M | 6.15% |
| Oct 31, 2005 | 4.69B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.63B |
| Labcorp Holdings | 14.14B |
| Quest Diagnostics | 11.28B |
| IDEXX Laboratories | 4.45B |
| Illumina | 4.39B |
| Mettler-Toledo International | 4.09B |
| Waters | 3.77B |
| Revvity | 2.90B |
A News
- 1 day ago - Agilent to Participate in Jefferies Global Healthcare Conference - Business Wire
- 8 days ago - Agilent appoints Michael Buckner as CLO - TheFly
- 8 days ago - Agilent Names Michael Buckner as Chief Legal Officer - Business Wire
- 14 days ago - Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27 - Business Wire
- 20 days ago - Labcorp announces availability of Agilent’s PD-L1 IHC 22C3 pharmDx - TheFly
- 21 days ago - Axion BioSystems and Agilent Technologies Resolve Litigation - Business Wire
- 27 days ago - Agilent showcases cancer research solutions at AACR 2026 - TheFly
- 27 days ago - Agilent Showcases Cancer Research Solutions at AACR 2026 - Business Wire